Development and Scale-Up of an Enabling Synthetic Route to KTX-005, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia

Post time Half hour(s) ago

journal：Organic Process Research & Development

Authors：Hanchao Zheng; Rui Zhang; Michel Leeman; Christopher R. H. Hale; Giorgio Attardo; Vijaya B. Gondi

Published date：2025-2-21

DOI：10.1021/acs.oprd.4c00531

PDF link：https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.4c00531

Article link：https://doi.org/10.1021/acs.oprd.4c00531

Article Source：American Chemical Society (ACS)。

Remark：

Post time 29 min. ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

Post time 29 min. ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[ACS] Development and Scale-Up of an Enabling Synthetic Route to KTX-005, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Development and Scale-Up of an Enabling Synthetic Route to KTX-005, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Development and Scale-Up of an Enabling Synthetic Route to KTX-005, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia